Wiley Handbook of Current and Emerging Drug Therapies, Volumes 1-4 (v. 1-4)

Here is an all-encompassing reference tailored to the needs of research managers, chemists and biologists, clinical scientists, and executives in the pharmacology and biotechnology industry.  No other resource focuses on drug discovery and pharmaceutical research from this unique perspective combining scientific and business aspects of today's biotechnology.

Within every major therapeutic area, the Wiley Handbook of Current and Emerging Drug Therapies provides a general overview of the etiology and pathophsiology of the important disease indications. Then, you'll find a comprehensive analysis of currently approved drugs targeting these diseases, with information on mechanism of action, efficacy, side effects and future prospects. You'll also find product-by-product analyses of drugs currently in development, including mechanism of action, formulations, and detailed information on the status of clinical trials.

This reference also includes authoritative essays on key topics:

• The Drug Discovery Process—Overview
  [Dr. Hugo Kubinyi of the University of Heidelberg]
• Clinical Trials—Overview
  [Dr. Curtis L. Meinert, Director of the Johns Hopkins Center for Clinical Trials]

and detailed, market-oriented analyses of:

• Emerging Technologies and Business Opportunities
• Global Markets and National Policy
• New Opportunities in Drug Discovery and Pipeline Development

Also available in a regularly-updating online version. Visit www.interscience.wiley.com/mrw/cedt for more information.